Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Pharmadigm enters agreement with Mipharm for PB-005

Jan. 26, 1999

Novel antiallergic agents from Nissan act as both substance P and histamine antagonists

Jan. 26, 1999

Meta-analysis supports first-line use of inhaled corticosteroids for allergic rhinitis

Jan. 21, 1999

IntraBiotics initiates phase I clinical trial of protegrin IB-367 aerosol

Jan. 21, 1999

InKine investigates Syk kinase inhibitors for asthma, other inflammatory conditions

Jan. 19, 1999

Licensing opportunity announced: liposomal compound for treatment of ARDS

Jan. 19, 1999

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

Jan. 19, 1999

Research at Jouveinal leads to potent and selective PDE4 inhibitors

Jan. 18, 1999

Teijin in-licenses novel asthma therapeutic from Byk Gulden

Jan. 18, 1999

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...